131 related articles for article (PubMed ID: 19764831)
21. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
23. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
Dehkordi LS; Liu ZD; Hider RC
Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
[TBL] [Abstract][Full Text] [Related]
24. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
[TBL] [Abstract][Full Text] [Related]
25. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
26. Iron chelation therapy for malaria.
Gordeuk VR; Thuma PE; Brittenham GM
Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
[No Abstract] [Full Text] [Related]
27. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).
Meshnick SR; Yang YZ; Lima V; Kuypers F; Kamchonwongpaisan S; Yuthavong Y
Antimicrob Agents Chemother; 1993 May; 37(5):1108-14. PubMed ID: 8517699
[TBL] [Abstract][Full Text] [Related]
28. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
30. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
[TBL] [Abstract][Full Text] [Related]
31. Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria.
Coghi P; Basilico N; Taramelli D; Chan WC; Haynes RK; Monti D
ChemMedChem; 2009 Dec; 4(12):2045-53. PubMed ID: 19844934
[TBL] [Abstract][Full Text] [Related]
32. Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins.
Klonis N; Creek DJ; Tilley L
Curr Opin Microbiol; 2013 Dec; 16(6):722-7. PubMed ID: 23932203
[TBL] [Abstract][Full Text] [Related]
33. Artemisinins: activities and actions.
Haynes RK; Krishna S
Microbes Infect; 2004 Nov; 6(14):1339-46. PubMed ID: 15555542
[TBL] [Abstract][Full Text] [Related]
34. The biochemical basis for the selective antimalarial action of iron chelators on Plasmodium falciparum parasitized cells.
Lytton SD; Loyevsky M; Libman J; Mester B; Shanzer A; Cabantchik ZI
Adv Exp Med Biol; 1994; 356():385-97. PubMed ID: 7887244
[No Abstract] [Full Text] [Related]
35. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
36. The Nobel Prize in Medicine 2015: Two drugs that changed global health.
Croft SL; Ward S
Sci Transl Med; 2015 Dec; 7(316):316ed14. PubMed ID: 26631629
[No Abstract] [Full Text] [Related]
37. The Evaluation of Metal Co-ordinating Bis-Thiosemicarbazones as Potential Anti-malarial Agents.
Akladios FN; Andrew SD; Boog SJ; de Kock C; Haynes RK; Parkinson CJ
Med Chem; 2019; 15(1):51-58. PubMed ID: 29804537
[TBL] [Abstract][Full Text] [Related]
38. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
[TBL] [Abstract][Full Text] [Related]
39. Reversed siderophores act as antimalarial agents.
Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
[TBL] [Abstract][Full Text] [Related]
40. Antimalarial properties of orally active iron chelators.
Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]